Status:
TERMINATED
Validation of 18F-MISO-PET and 18F-FLT-PET
Lead Sponsor:
Radboud University Medical Center
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Hypoxia and tumor cell proliferation are important mechanisms contributing to resistance to radiotherapy in human head and neck tumor cells. Currently, assessment of these two tumor characteristics is...
Eligibility Criteria
Inclusion
- Stage II-IV squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx, planned for curative resection.
- Age \>18 years.
- Written informed consent.
Exclusion
- Pregnancy.
- Prior treatment for this tumor
- Women breast feeding
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00159978
Start Date
July 1 2005
End Date
December 1 2013
Last Update
May 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC St Radboud, Department of Radiotherapy
Nijmegen, Gelderland, Netherlands, 6500 HB